ArticleScience translational medicine2017

Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade.

Martina Schmittnaegel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.